Simple blood test can determine risk of breast cancer death or relapse
This recent study published in the Lancet Oncology is very interesting and exciting. One of the big challenges that oncologists face when trying to determine the aggressiveness of a cancer is poorly understood. There are limited tools to help determine whether or not after primary treatment of a cancer, there is a need to follow up with either chemotherapy or radiation. This latest research pointing to the fact that the presence of tumor cells in blood may help predict the aggressiveness of a cancer’s tumor could lead researchers to develop better clinical protocols to treat some of the most challenging cancers that we face. Click here to read more.